Evommune Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights March 6, 2026
BBOT Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress March 6, 2026
TScan Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update March 5, 2026
TScan Therapeutics Completes Enrollment in Cohort C of Phase 1 ALLOHA™ Trial and Announces FDA Clearance of Investigational New Drug Applications for Heme Candidates TSC-102-A01 and TSC-102-A03 February 27, 2026
BridgeBio Reports Fourth Quarter and Full Year 2025 Financial Results and Commercial Updates February 27, 2026
Boehringer pens $500M pact with British biotech for oral approach to autoimmune diseases February 26, 2026
